Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients

Metabolism: Clinical and Experimental

Volumn 46, Issue 2, 1997, Pages 227-233

  Féry, Françoise ^a   Plat, Laurence ^b   Balasse, Edmond O ^b  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; GLUCOSE; METFORMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; GLUCOSE UTILIZATION; GLYCOLYSIS; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031046921     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90307-3     Document Type: Article

References (41)

1. Bailey CJ: Biguanides and NIDDM. Diabetes Care 15:755-772, 1992
2. Bergman U, Boman G, Wiholm BE: Epidemiology of adverse drug reactions to phenformin and metformin. Br Med J 2:464-466, 1978
3. Vigneri R, Goldfine ID: Role of metformin in treatment of diabetes mellitus. Diabetes Care 10:118-122, 1987
4. Jackson RA, Hawa MI, Jaspan JB, et al: Mechanism of metformin action in non-insulin-dependent diabetes. Diabetes 36:632-640, 1987
5. Stumvoll M, Nurjhan N, Perriello G, et al: Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333:550-554, 1995
6. Bailey CJ, Wilcock C, Day C: Effect of metformin on glucose metabolism in the splanchnic bed. Br J Pharmacol 105:1009-1013, 1992
7. Penicaud L, Hitier Y, Ferre P, et al: Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine. Biochem J 262:881-885, 1989
8. Hother-Nielsen O, Schmitz O, Andersen PH, et al: Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. Acta Endocrinol (Copenh) 120:257-265, 1989
9. McIntyre HD, Bird DM, Paterson CA, et al: Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin-dependent) diabetes mellitus. Aust NZ J Med 21:714-719, 1991
10. Johnson AB, Webster JM, Sum CF, et al: The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Metabolism 42:1217-1222, 1993
11. DeFronzo RA, Barzilai N, Simonson DC: Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab 73:1294-1301, 1991
12. Widén EIM, Eriksson JG, Groop LC: Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. Diabetes 41:354-358, 1992
13. Féry F, Balasse EO: Glucose metabolism during the starved-tofed transition in obese patients with NIDDM. Diabetes 43:1418-1425, 1994
14. Golay A, Felber JP, Jéquier E, et al: Metabolic basis of obesity and noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 4:727-747, 1988
15. Eriksson J, Franssila-Kalunki A, Ekstrand A, et al: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
16. Féry F, D'Attellis NP, Balasse EO: Mechanisms of starvation diabetes: Study with double tracer and indirect calorimetry. Am J Physiol 259:E770-E777, 1990
17. Del Prato S, Bonadonna RC, Bonora E, et al: Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest 91:484-494, 1993
18. Féry F, Melot C, Balasse EO: Glucose fluxes and oxidation after an oral glucose load in patients with non-insulin-dependent diabetes mellitus of variable severity. Metabolism 42:522-530, 1993
19. Bergmeyer HU: Methods of Enzymatic Analysis (ed 2). New York, NY, Academic, 1974
20. Morgan CR, Lazarow A: Immunoassay of insulin: Two antibody systems. Plasma insulin levels of normal subdiabetic and diabetic rats. Diabetes 12:115-126, 1963
21. Faloona GR, Unger RH: Glucagon, in Jaffe BM, Behrman HR (eds): Methods of Hormone Radioimmunoassay. New York, NY, Academic, 1974, pp 317-330
22. Steele R: Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sei 82:420-430, 1959
23. Radziuk J, MacDonald T, Rubenstein D, et al: Initial splanchnic extraction of ingested glucose in normal man. Metabolism 27:657-669, 1978
24. Ferrannini E, Bjorkman O, Reichard GA Jr, et al: The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes 34:580-588, 1985
25. Ferrannini E: The theoretical basis of indirect calorimetry: A review. Metabolism 37:287-301, 1988
26. Tappy L, Owen OE, Boden G: Effect of hyperinsulinemia on urea pool size and substrate oxidation rates. Diabetes 37:1212-1216, 1988
27. Gottesman I, Mandarino L, Gerich J: Use of glucose uptake and glucose clearance for the evaluation of insulin action in vivo. Diabetes 33:184-191, 1984
28. Hollenbeck CB, Johnston P, Varastch BB, et al: Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridemia and non-insulin-dependent diabetes by glucose tolerance test criteria. Diabete Metab 17:483-489, 1991
29. Rossetti L, Giaccari A: Contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest 84:892-899, 1989
30. Rossetti L, Lee YT, Ruiz J, et al: Quantification of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol 265:E761-E769, 1993
31. Rossetti L, DeFronzo RA, Gherzi R, et al: Effect of metformin treatment on insulin action in diabetic rats: In vivo and in vitro correlations. Metabolism 39:425-435, 1990
32. Jackson RA, Roshania RD, Hawa MI, et al: Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: An analysis based on simultaneous use of the forearm and double isotope techniques. J Clin Endocrinol Metab 63:541-549, 1986
33. Radziuk J, Inculet R: The effects of ingested and intravenous glucose on forearm uptake of glucose and glucogenic substrate in normal man. Diabetes 32:977-981, 1983
34. Bratusch-Marrain PR, Korn A, Waldhäusl WK, et al: Effect of buformin on splanchnic carbohydrate and substrate metabolism in healthy man. Metabolism 30:946-952, 1981
35. Wu MS, Johnston P, Sheu WHH, et al: Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care 13:1-8, 1990
36. Prager R, Schernthaner G, Graf H: Effect of metformin on peripheral insulin sensitivity in non-insulin-dependent diabetes mellitus. Diabete Metab 12:346-350, 1986
37. Nosadini R, Avogaro A, Travisan R, et al: Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes. Diabetes Care 10:62-67, 1987
38. Galuska D, Zierath J, Thorne A, et al: Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle. Diabete Metab 17:159-163, 1991
39. Consoli A, Nurjhan N, Gerich JE, et al: Skeletal muscle is a major site of lactate uptake and release during hyperinsulinemia. Metabolism 41:176-179, 1992
40. Mitrakou A, Kelley D, Veneman T, et al: Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39:1381-1390, 1990
41. Kelley D, Mokan M, Veneman T: Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism 43:1549-1557, 1994